Abstract:I read with great interest the article by Das et al. Although presence of nonalcoholic fatty liver (NAFL) in nonobese individuals is a fairly common observation in India, this is the first such scientific documentation for the same. However, I would like to make a few points in this regard. First, NAFL constitutes a wide spectrum of liver disease with varied natural history extending from simple steatosis to more sinister variants, i.e., nonalcoholic steatohepatitis (NASH) and fibrosis/cirrhosis. Only a proportion of NAFL actually progresses to the more sinister end of this spectrum. Therefore, instead of a blanket focus on NAFL, it would be more appropriate to identify the subset of patients with NAFL who are more likely to progress to NASH. In this regard, the authors have defined ‘‘potentially significant NAFL’’ as ‘‘subjects with definite NAFL who had persistently elevated ALT (>40 IU/L)’’. However, even in this study only one-third of these subjects with ‘‘potentially significant NAFL’’ were found to have NASH on liver biopsy, which means elevated ALT alone is not a good enough marker of ‘‘potentially significant’’ NAFL. A full panel of noninvasive markers of liver fibrosis would be more appropriate to define this subset and save costly and/or potentially harmful procedures like liver biopsy or computed tomography scans for them. Second, although the authors have claimed to have excluded people with alcohol consumption from this study, this population in context comes largely from a tribal background who indulges in many nonconventional forms of ethanol consumption, e.g., mahua flower (Madhuca longifolia). It would be interesting to know if the authors have ruled out those possibilities as well. Third, risk of NAFL is undoubtedly associated with obesity and metabolic syndrome and has been traditionally associated with more affluent living standards. In the current study too, even nonobese subjects with NAFL had worse metabolic parameters and higher income than their age-matched and sex-matched counterparts who did not have NAFL. Nevertheless, coexistence of intrauterine and neonatal malnutrition and the development of obesity, type 2 diabetes, and related comorbidities have been confirmed in a number of studies in humans and animal models. Moreover, it has been shown that, in humans, the intrahepatic lipid content increase following starvation also may be due to reduced apolipoprotein B-100 production and hepatic lipid export, and/or impaired mitochondrial function; this could have implications for exacerbations of steatohepatitis that is sometimes seen with rapid weight loss, anorexia nervosa, and parenteral nutrition. Therefore, in contrast to the popular view, malnutrition rather than obesity at different stages of life may well be an explanation for pathogenesis of NAFL in this predominantly poor population.

NAFLD Leads to Liver Cancer: Do We Have Sufficient Evidence?

Causal Association of Nonalcoholic Fatty Liver Disease with 22 Extrahepatic Cancers: A Mendelian Randomization Study.

Associations Between Nonalcoholic Fatty Liver Disease and Cancers in a Large Cohort in China

Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis

Nonalcoholic fatty liver disease is associated with intrahepatic cholangiocarcinoma and not with extrahepatic form: definitive evidence from meta-analysis and trial sequential analysis

Is Cigarette Smoking an Independent Risk Factor or a Cofactor for Nonalcoholic Fatty Liver Disease?

NAFLD-Related HCC: Focus on the Latest Relevant Preclinical Models

Association of nonalcoholic fatty liver disease and liver cancer

NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis

Is non-alcoholic fatty liver disease the risk factor for the occurrence of primary bronchogenic carcinoma

Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link

Association between non-alcoholic fatty liver disease and colorectal cancer

Fatty liver is associated with significant liver inflammation but does not increase fibrosis burden in Chronic Hepatitis B

The Role of Dietary Factors in Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma Progression: A Systematic Review.

Influence of Nonalcoholic Fatty Liver Disease With Increased Liver Enzyme Levels on the Risk of Cirrhosis and Hepatocellular Carcinoma

Non-alcoholic fatty liver disease promotes breast cancer progression through upregulated hepatic fibroblast growth factor 21

Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease

The Latest Research Progress of Non-alcoholic Fatty Liver Disease-related Hepatocellular Carcinoma

Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation

Linking fatty liver diseases to hepatocellular carcinoma by hepatic stellate cells

Obesity, Fatty Liver and Liver Cancer